Mankind Pharma Sees 13.13% Surge in Open Interest Amid Price Decline

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 15,275 contracts, reflecting a rise of 1,773 contracts or 13.13% from the previous open interest of 13,502. This uptick in open interest comes alongside a trading volume of 9,507 contracts, indicating active participation in the market. Despite this increase in open interest, Mankind Pharma's stock performance has been underwhelming, underperforming its sector by 1.19%. The stock has faced consecutive declines over the past three days, resulting in a total drop of 5.28%. Today, it opened with a loss of 2.56%, reaching an intraday low of Rs 2,248.6, down 2.62% from the previous close. In terms of liquidity, the stock remains accessible for trading, with a delivery volume of 312,000 shares on November 6, marking a 42.69% increase compared to the five-day average. Mankind Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position. Overall, the increase in open interest highlights a shift in market dynamics, even as the stock grapples with recent performance challenges.